Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PT150 in Alcohol Use Disorder
NCT06712602Phase 1Recruiting
- Sponsor
- Pop Test Oncology LLC
- Start
- Feb 2025
- Primary completion
- Jul 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of ORG-34517 in alcohol use disorder (AUD) (2 arms), sponsored by Pop Test Oncology LLC. Primary endpoints: Change in salivary cortisol (alcohol) up to 34 days, Change in salivary cortisol (stress induction) up to 34 days and 3 more. Started Feb 2025; status: recruiting.
02
Drugs
ORG-34517
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT06712602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06712602.